Andreas Stensvold

455 total citations
29 papers, 280 citations indexed

About

Andreas Stensvold is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Andreas Stensvold has authored 29 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Andreas Stensvold's work include Prostate Cancer Diagnosis and Treatment (13 papers), Prostate Cancer Treatment and Research (11 papers) and Cancer survivorship and care (3 papers). Andreas Stensvold is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (13 papers), Prostate Cancer Treatment and Research (11 papers) and Cancer survivorship and care (3 papers). Andreas Stensvold collaborates with scholars based in Norway, United States and Sweden. Andreas Stensvold's co-authors include Wolfgang Lilleby, Alv A. Dahl, Sophie D. Fosså, Karol Axcrona, Jahn M. Nesland, Ian G. Mills, Lars Magne Eri, Tom Wilsgaard, Hanne Frydenberg and Bjørn Brennhovd and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Andreas Stensvold

26 papers receiving 275 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Stensvold Norway 10 152 99 69 46 37 29 280
Sally Elsamanoudi United States 8 336 2.2× 73 0.7× 103 1.5× 66 1.4× 64 1.7× 15 428
P. Stattin Sweden 5 271 1.8× 133 1.3× 41 0.6× 61 1.3× 42 1.1× 6 369
Pablo Fernández Spain 6 314 2.1× 94 0.9× 33 0.5× 79 1.7× 22 0.6× 7 380
Lluís Fumadó Spain 12 228 1.5× 43 0.4× 75 1.1× 47 1.0× 81 2.2× 38 341
Lisel Koepl United States 11 87 0.6× 156 1.6× 33 0.5× 33 0.7× 58 1.6× 12 325
Jan Herden Germany 10 190 1.3× 61 0.6× 93 1.3× 68 1.5× 114 3.1× 39 367
Ana Fröbe Croatia 9 146 1.0× 56 0.6× 24 0.3× 96 2.1× 55 1.5× 41 334
Francesco Cortiula Italy 10 170 1.1× 202 2.0× 48 0.7× 35 0.8× 51 1.4× 38 324
R.G.H.M. Cremers Netherlands 8 142 0.9× 43 0.4× 37 0.5× 28 0.6× 35 0.9× 16 222
William P. McLaughlin United States 3 244 1.6× 125 1.3× 16 0.2× 87 1.9× 43 1.2× 6 357

Countries citing papers authored by Andreas Stensvold

Since Specialization
Citations

This map shows the geographic impact of Andreas Stensvold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Stensvold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Stensvold more than expected).

Fields of papers citing papers by Andreas Stensvold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Stensvold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Stensvold. The network helps show where Andreas Stensvold may publish in the future.

Co-authorship network of co-authors of Andreas Stensvold

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Stensvold. A scholar is included among the top collaborators of Andreas Stensvold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Stensvold. Andreas Stensvold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stensvold, Andreas, et al.. (2024). Anticancer therapy at end-of-life: A retrospective cohort study. Acta Oncologica. 63. 313–321. 1 indexed citations
2.
Grov, Ellen Karine, et al.. (2024). Hospitalizations and re-hospitalizations at the end-of-life among cancer patients; a retrospective register data study. BMC Palliative Care. 23(1). 39–39. 2 indexed citations
3.
Guribye, Frode, et al.. (2024). Tangible Interactions for Pain Assessment in Palliative Care. 1–15.
4.
Stensvold, Andreas, et al.. (2024). Real-world Data on Treatment Patterns and Bleeding in Cancer-associated Thrombosis: Data from the TROLL Registry. SHILAP Revista de lepidopterología. 8(1). e132–e140. 1 indexed citations
5.
Helland, Åslaug, Geir Olav Hjortland, Line Bjørge, et al.. (2023). 1235P Enrichment of rare cancers in pragmatic precision cancer medicine trial: Experience from IMPRESS-Norway. Annals of Oncology. 34. S721–S722.
6.
Stensvold, Andreas, et al.. (2023). Multivariate Statistical Process Control and Classification Applied on Prostate Cancer Screening. Journal of Biomedical Research & Environmental Sciences. 4(6). 1030–1038.
7.
Bjerner, Johan, Ola Bratt, Peter C. Albertsen, et al.. (2023). Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death—Results from the Norwegian Prostate Cancer Consortium. European Urology. 86(1). 20–26. 4 indexed citations
8.
Stensvold, Andreas, et al.. (2023). Novel insights into mTOR signalling pathways: A paradigm for targeted tumor therapy. 6(0). e2023017–e2023017. 1 indexed citations
9.
Leonardsen, Ann‐Chatrin Linqvist, et al.. (2022). Cancer patients’ perspectives on remote monitoring at home during the COVID-19 pandemic- a qualitative study in Norway. BMC Health Services Research. 22(1). 453–453. 6 indexed citations
10.
Mortensen, Elin, Hawa Nalwoga, Tom Wilsgaard, et al.. (2018). Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes. BMC Cancer. 18(1). 654–654. 66 indexed citations
11.
12.
13.
14.
Stensvold, Andreas, Alv A. Dahl, Bjørn Brennhovd, et al.. (2012). Bother problems in prostate cancer patients after curative treatment. Urologic Oncology Seminars and Original Investigations. 31(7). 1067–1078. 26 indexed citations
15.
16.
Stensvold, Andreas, Alv A. Dahl, Bjørn Brennhovd, et al.. (2011). Methods for prospective studies of adverse effects as applied to prostate cancer patients treated with surgery or radiotherapy without hormones. The Prostate. 72(6). 668–676. 7 indexed citations
17.
Stensvold, Andreas, Alv A. Dahl, Sophie D. Fosså, et al.. (2010). Clinicians' use of guidelines as illustrated by curative treatment of prostate cancer at a comprehensive cancer center. Acta Oncologica. 50(3). 408–414. 7 indexed citations
18.
Strand, Trond‐Eirik, Dag Clement Johannessen, Stein Sundstrøm, et al.. (2010). Potentially Curative Radiotherapy for Non–Small-Cell Lung Cancer in Norway: A Population-Based Study of Survival. International Journal of Radiation Oncology*Biology*Physics. 80(1). 133–141. 10 indexed citations
19.
Stensvold, Andreas, et al.. (2007). Computed tomography enhancement characteristics of lymphomatous lymph nodes of the neck. Dentomaxillofacial Radiology. 36(4). 234–236. 3 indexed citations
20.
Stensvold, Andreas, Rolf Jorde, & Johan Sundsfjord. (1997). Late and transient increases in free T4 after radioiodine treatment for Graves’ disease. Journal of Endocrinological Investigation. 20(10). 580–584. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sally Elsamanoudi Breakdown of academic impact, for papers by P. Stattin Breakdown of academic impact, for papers by Pablo Fernández Breakdown of academic impact, for papers by Lluís Fumadó Breakdown of academic impact, for papers by Lisel Koepl Breakdown of academic impact, for papers by Jan Herden Breakdown of academic impact, for papers by Ana Fröbe Breakdown of academic impact, for papers by Francesco Cortiula Breakdown of academic impact, for papers by R.G.H.M. Cremers Breakdown of academic impact, for papers by William P. McLaughlin
Rankless by CCL
2026